CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...
Phase 3
London, United Kingdom and 92 other locations
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
London, United Kingdom and 13 other locations
The COPELIA trial is evaluating two new tablet medications in endometrial cancer for the first time. It will include 129 women aged ...
Phase 2
London, United Kingdom and 14 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
London, United Kingdom and 162 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
London, United Kingdom and 168 other locations
This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profile...
Phase 1
London, United Kingdom and 18 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
London, United Kingdom and 92 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
London, United Kingdom and 123 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...
Phase 1, Phase 2
Sutton, United Kingdom and 50 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
London, London, City Of, United Kingdom and 230 other locations
Clinical trials
Research sites
Resources
Legal